Influence of MLC leaf width on biologically adapted IMRT plans

Acta Oncologica

Volumn 49, Issue 7, 2010, Pages 1116-1123

  Rødal, Jan ^a,b   Søvik, Åste ^a,c   Malinen, Eirik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; DEVICE; DOG; DOSE VOLUME HISTOGRAM; FEMALE; HISTOGRAM; HYPOXIA; INTENSITY MODULATED RADIATION THERAPY; MULTILEAF COLLIMATOR; NONHUMAN; NOSE CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PRIORITY JOURNAL; RADIATION DOSE;

ANIMALS; CARCINOMA; DOG DISEASES; DOGS; DOSE FRACTIONATION; FEMALE; MODELS, THEORETICAL; NOSE NEOPLASMS; PHANTOMS, IMAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TUMOR BURDEN;

EID: 77956604128     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.498832     Document Type: Article

References (32)

1. Steel GG. Basic clinical radiobiology, 3rd ed. London: Hodder Arnold Publication; 2002.
2. Sovik A, Malinen E, Olsen DR. Strategies for biologic image-guided dose escalation: A review. Int J Radiat Oncol Biol Phys 2009;73:650-658
3. Chao KSC, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2001;49: 1171-1182
4. Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47:551-560
5. Petit SF, Dekker A, Seigneuric R, Murrer L, van Riel NAW, Nordsmark M, et al. Intra-voxel heterogeneity infl uences the dose prescription for dose-painting with radiotherapy: A modelling study. Phys Med Biol 2009;54:2179-96.
6. Tanderup K, Olsen DR, Grau C. Dose painting: Art or science? Radiother Oncol 2006;79:245-248
7. Roe K, Muren LP, Rorvik J, Olsen DR, Dahl O, Bakke A, et al. Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. Acta Oncol 2008;47:1257-1264
8. Bortfeld T, Oelfke U, Nill S. What is the optimum leaf width of a multileaf collimator? Med Phys 2000;27:2494-2502
9. Shepard DM, Olivera G, Angelos L, Sauer O, Reckwerdt P, Mackie TR. A simple model for examining issues in radiotherapy optimization. Med Phys 1999;26:1212-1221
10. Wu VWC. Effects of multileaf collimator parameters on treatment planning of intensity-modulated radiotherapy. Med Dosim 2007;32:38-43.
11. Ding MS, Newman F, Chen CH, Stuhr K, Gaspar LE. Dosimetric comparison between 3dcrt and Imrt using different multileaf collimators in the treatment of brain tumors. Med Dosim 2009;34:1-8.
12. Fiveash JB, Murshed H, Duan J, Hyatt M, Caranto J, Bonner JA, et al. Effect of multileaf collimator leaf width on physical dose distributions in the treatment of CNS and head and neck neoplasms with intensity modulated radiation therapy. Med Phys 2002;29:1116-1119
13. Malinen E, Sovik A, Hristov D, Bruland OS, Olsen DR. Adapting radiotherapy to hypoxic tumours. Phys Med Biol 2006;51:4903-4921
14. Sovik A, Malinen E, Skogmo HK, Bentzen SM, Bruland OS, Olsen DR. Radiotherapy adapted to spatial and temporal variability in tumor hypoxia. Int J Radiat Oncol Biol Phys 2007;68:1496-1504
15. Sovik A, Malinen E, Bruland OS, Bentzen SM, Olsen DR. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: A modelling study. Phys Med Biol 2007;52:499-513.
16. Yang Y, Xing L. Towards biologically conformal radiation therapy (BCRT): Selective IMRT dose escalation under the guidance of spatial biology distribution. Med Phys 2005; 32:1473-1484
17. Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 1997;24: 103-110
18. South CP, Evans PM, Partridge M. Dose prescription complexity versus tumor control probability in biologically con-formal radiotherapy. Med Phys 2009;36:4379-4388
19. Pettersen MN, Aird E, Olsen DR. Quality assurance of dosimetry and the impact on sample size in randomized clinical trials. Radiother Oncol 2008;86:195-199
20. Thorwarth D, Eschmann SM, Paulsen F, Alber M. Hypoxia dose painting by numbers: A planning study. Int J Radiat Oncol Biol Phys 2007;68:291-300.
21. Kim Y, Tome WA. Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans. Acta Oncol 2008;47:906-916
22. Sauer OA, Wilbert J. Measurement of output factors for small photon beams. Med Phys 2007;34:1983-1988
23. Bentzen SM. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 2005;6: 112-117
24. Hall EJ, Wuu CS. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003;56:83-88
25. Yang RJ, Xu SP, Jiang WJ, Wang JJ, Xie CB. Dosimetric comparison of postoperative whole pelvic radiotherapy for endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy. Acta Oncol 2010;49:230-236
26. Johansen J, Bertelsen A, Hansen CR, Westberg J, Hansen O, Brink C. Set-up errors in patients undergoing image guided radiation treatment. Relationship to body mass index and weight loss. Acta Oncol 2008;47:1454-1458
27. van Kranen S, van Beek S, Rasch C, van Herk M, Sonke JJ. Setup uncertainties of anatomical sub-regions in head-and-neck cancer patients after Offline Cbct guidance. Int J Radiat Oncol Biol Phys 2009;73:1566-1573
28. Bertelsen A, Nielsen M, Westberg J, Jensen HR, Brink C. The representitativeness of patient position during the fi rst treatment fractions. Acta Oncol 2009;48:259-266
29. Vanderstraeten B, Duthoy W, De Gersem W, De Neve W, Thierens H. [F-18]fluoro-deoxy-glucose positron emission tomography ([F-18]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. Radiother Oncol 2006;79:249-258
30. Gregoire V. Is there any future in radiotherapy planning without the use of PET: Unraveling the myth. Radiother Oncol 2004;73:261-263
31. Grosu AL, Piert M, Molls M. Experience of PET for target localisation in radiation oncology. Br J Radiol 2005;78: 18-32.
32. Toma-Dasu I, Dasu A, Brahme A. Dose prescription and optimisation based on tumour hypoxia. Acta Oncol 2009; 48:1181-1192